DEPDC1 and neoplasm: As a result, the glycolysis-related biomarker DEP domain containing 1 (DEPDC1), which is a part of a transcription repressor complex and a newly discovered tumor-associated gene [14], was identified as being associated with the prognosis of OSCC.